Log In
Print
BCIQ
Print
Print this Print this
 

AGT-181

  Manage Alerts
Collapse Summary General Information
Company ArmaGen Technologies Inc.
DescriptionRe-engineered human iduronidase (IDUA), where the lysosomal enzyme is fused to IgG, a monoclonal antibody (mAb)
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentPreclinical
IndicationNeurology
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today